TABLE 1.
Patient characteristics stratified by Patient-Oriented Eczema Measure severity
| Disease severity by Patient-Oriented Eczema Measure (POEM) | |||||
|---|---|---|---|---|---|
| Total (n = 60) | Mild AD (n = 10) |
Moderate AD (n = 25) |
Severe AD (n = 25) |
p-Value | |
| Age, mean (SD) | 2.78 (0.98) | 2.21 (0.99) | 3.00 (0.93) | 2.80 (0.97) | .10 |
| Male, n (%) | 33 (5S) | 7 (70) | 16 (64) | 10 (40) | .14 |
| Race/Ethnicity | .92 | ||||
| Caucasian, n (%) | 21 (35) | 3 (30) | 9 (36) | 9 (36) | |
| Black, n (%) | 19 (32) | 3 (30) | 8 (36) | 8 (32) | |
| Other, n (%) | 20 (33) | 4 (30) | 8 (28) | 8 (32) | |
| Parental education levels | .53 | ||||
| High school graduate(%) | 2 (3) | 0 | 0 | 2 (8) | |
| Some college or BA (%) | 40 (67) | 7 (70) | 18 (72) | 15 (60) | |
| Higher degree (PhD., master's)(%) | 18 (30) | 3 (30) | 7 (28) | 8 (32) | |
| Household income in past 12 months | <.01 | ||||
| <$30,000 (%) | 6 (10) | 0 | 2 (8) | 4 (16) | |
| $30,000–$74,999 (%) | 32 (53) | 3 (30) | 9 (36) | 20 (80) | |
| >$75,000 (%) | 19 (32) | 7 (70) | 11 (44) | 1 (4) | |
| Omitted (%) | 1 (4) | 0 | 1 (4) | 0 | |
| Sleep disturbance (nights of disturbed sleep) | <.01 | ||||
| 1–2 days, n (%) | 16 (27) | 6 (60) | 8 (32) | 2 (8) | |
| 3–4 days, n (%) | 14 (23) | 0 | 11 (44) | 3 (12) | |
| 5–6 days, n (%) | 13 (22) | 0 | 6 (24) | 7 (28) | |
| Every day, n (%) | 12 (20) | 0 | 0 | 12 (48) | |
| No day, n (%) | 5 (8) | 4 (40) | 0 | 1(4) | |
| Skin treatment (yes) | 52 (87) | 6 (60) | 22 (88) | 24 (96) | .02 |
| POEM (SD) | 15.25 (6.30) | 5.60 (1.65) | 13.00 (2.22) | 21.36 (2.96) | <.01 |
| PROMIS Early Childhood Sleep Health T-score (SD) | 65.16 (8.87) | 53.60 (8.03) | 64.83 (5.99) | 70.11 (7.22) | <.01 |
| PROMIS EC Sleep Health score ≥60, n (%) | 44 (73) | 1 (10) | 20 (80) | 23 (92) | <.01 |
| IDQoL (SD) | 10.92 (5.29) | 4.30 (1.95) | 10.08 (3.49) | 14.40 (4.85) | <.01 |
| PIQ-C T-score (SD) | 51.28 (9.47) | 38.78 (6.81) | 51.39 (7.68) | 56.17 (9.47) | <.01 |
| Itch Severity Numeric Rating Scale (SD) | 5.93 (2.04) | 3.60 (1.78) | 5.40 (1.47) | 7.40 (0.44) | <.01 |
| MAPS-AR Composite Score (SD) | 45.55 (12.50) | 34.20 (8.40) | 43.52 (12.03) | 52.12 (10.47) | <.01 |
Note: Bold = statistically significant, p < .05.
Abbreviations: IDQoL, Infant Dermatitis Quality of Life Index; MAPS-AR, Multidimensional Assessment Profile of Attention Regulation; PIQ-C, Patient-Reported Outcomes Measurement Information System Itch Questionnaire—Child; POEM, Patient-Oriented Eczema Measure; PROMIS EC, Patient-Reported Outcomes Measurement Information System Early Childhood.